Skip to content
OOS Investigation Explained: Phase 1 vs Phase 2 (21 CFR 211.192) episode artwork

Oct 19, 2026 14 min

OOS Investigation Explained: Phase 1 vs Phase 2 (21 CFR 211.192)

from The GMP Insider

An out-of-specification result lands on your desk — and one wrong decision in the next hour can manufacture the evidence for your own warning letter. Marcus and Priya break down the two-phase OOS investigation step by step: Phase 1, the laboratory investigation, and Phase 2, the full-scale investigation, under 21 CFR 211.192 — from the Barr Labs decision to the retest rules to what to do on Monday morning. • Phase 1 vs Phase 2: what each phase covers and where the line is• The retest rules — when retesting is legitimate and when it's testing into compliance• Why "no assignable lab cause" is a finding, not a failure• What 21 CFR 211.192 actually requires, in plain language• The Monday-morning OOS playbook, in five steps New episodes every Monday and Wednesday — follow The GMP Insider so you never miss one.Connect with Tushar Arora on LinkedIn: https://www.linkedin.com/in/tushar-a-926382161Watch on YouTube: https://www.youtube.com/@TheGMPInsider Produced with AI assistance.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

OOS Investigation Explained: Phase 1 vs Phase 2 (21 CFR 211.192)

0:00 14:54

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of The GMP Insider?

This episode is 14 minutes long.

When was this The GMP Insider episode published?

This episode was published on October 19, 2026.

Can I download this The GMP Insider episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.